We detected elevated levels of HDAC11 expression in neuroblastomas and several carcinomas compared to corresponding healthy tissues, and showed that HDAC11 depletion was sufficient to cause apoptosis and inhibit metabolic activity in different cancer cell lines, representing major oncological indications for industrial drug development programs [39]. Here, HDAC11 is linked to neuroblastoma.